Side Area Image
Novita Healthcare Limited (ASX:NHL) is an Australian Medical Technology Company listed on the Australian Securities Exchange. Novita's core focus is the development of TALI Health and the TALI Technology.
1300 082 013
info@novitahealthcare.com.au

Scientific Advisory Board

HomeAbout UsScientific Advisory Board

PROFESSOR KIM CORNISH

Chair of the TALI Scientific Advisory Board

Professor Cornish is the Head of School of Psychological Sciences and Deputy Dean of the Faculty of Biomedical and Psychological Sciences at Monash University.

PROFESSOR GAIA SCERIF

Developmental Neuroscientist, Oxford University (UK)

Professor Scerif is a developmental neuroscientists at Oxford University in the UK.

PROFESSOR MARK BELLGROVE

Cognitive Neuroscientist, Monash University (AUS)

Professor Bellgrove is a cognitive neuroscientist in the School of Psychological Sciences at Monash University in Australia.

Professor Cornish is also the Director of the Monash Institute of Clinical and Cognitive Neurosciences.  Previously, she was the Canadian Research Chair in Developmental Neuroscience and Professor at McGill University.  She currently retains an Adjunct Professorship in the Department of Neurology & Neurosurgery at the Montréal Neurological Institute and is special professor in the Division of Developmental Psychiatry at Nottingham University in the UK.  Professor Cornish is recognised internationally for her work in the field of neurodevelopmental disorders, genetics and atypical cognitive pathways, particularly attention related atypicalities.

Previously Professor Scerif worked as a visiting fellow at the Sackler Institute of Developmental Psychobiology at Cornell University in the USA, and a lecturer in the School of Psychology at the University of Nottingham in the UK. Professor Scerif’s research focuses on the development of attentional control and those underlying attentional difficulties.

Professor Bellgrove is currently Chair of Research Strategy in the School of Psychological Sciences at Monash University.   He undertook his post-doctoral training at the Institute of Neuroscience at Trinity College in the UK.  He returned to Australia and the University of Melbourne under a prestigious NHMRC Howard Florey Centenary Fellowship. He later relocated to the Queensland Brain Institute at the University of Queensland as part of an initiative to develop cognitive neuroscience at this institution.  Professor Bellgrove as been awarded an NHMRC Career Development Award (Level 2), multiple NHMRC and ARC project grants and Future Fellowship (Level 3) from the Australian Research Council.  His research focuses on the biological basis of attention and uses state-of-the-art cognitive neuroscience suites alongside molecular facilities for functional genomics.  His research team has made significant progress in defining the genetic architecture of attention.

PROFESSOR VICKI ANDERSON

Developmental Neuropyschologist, Murdoch Children’s Research Institute (AUS)

Professor Anderson is a paediatric neuropsychologist at the Murdoch Childrens Research Institute with over 30 years’ experience.

DR JANE ROBERTS

Developmental & Educational Pyschologist, University of South Carolina (USA)

Dr Roberts is an educational and developmental psychologist at the University of South Carolina.

Dr Kirk is a developmental neuroscientist who completed her PhD at Monash University in the Institute of Cognitive and Clinical Neurosciences.  Dr Kirk was one of the inventors of the TALI system and conducted the first clinical trial to evaluate the benefits of this Technology.

Dr Kirk has published 10 peer-reviewed articles in highly regarded journals, presented at both national and international conferences and been the recipient of several research and industry based awards.  She currently retains an Adjunct Research Fellowship in the Institute of Cognitive and Clinical Neurosciences at Monash University.

As part of the TALI Health team, Dr Kirk’s goal is to design scientifically driven tasks that benefit cognition and behaviour in both typically developing children and clinical populations.

Dr Roberts previously worked at the FPG Child Development Institute at the University of North Carolina.  Her work focuses on understanding the biological mechanisms that underlie cognitive and behavioral functioning in children and adults with neurodevelopmental disorders such as autism, fragile X syndrome, and AD/HD.